title: Switching from i.v. to s.c. epoetin in hemodialysis patients.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Knauss
authors.forename: Ted
authors.initials: T
authors.lastname: Walton
authors.forename: Edwin J
authors.initials: EJ
authors.lastname: Macon
mesh_terms: D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D005260:Female; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa